Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD) is Buildings and Property in France that focus on commercialization rights business. They cover business area such as intellectual property and commercialization right, lipase enzyme, exocrine pancreatic insufficiency.
-
Commercialization Rights
-
6, avenue de l'Europe
78401 Chatou Cedex
France
Private
intellectual property and commercialization rightlipase enzymeexocrine pancreatic insufficiency
* We use standard office opening hours in near Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Laboratoires Mayoly Spindler (Intellectual Property Of MS1819-SD) is Buildings and Property business from France that founded in - ( years old in ), Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD) business is focusing on Commercialization Rights.
Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD) headquarter office and corporate office address is located in 6, avenue de l'Europe 78401 Chatou Cedex France.
Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD) was founded in France.
In , Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD) is currently focus on commercialization rights sector.
Above is snippet of Google Trends for "commercialization rights" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Laboratoires Mayoly Spindler (Intellectual Property of MS1819-SD), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
